Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 200,691 | 214,310 | 48,003 | 1,365 | -1,956 |
| Depreciation Amortization | 3,225 | 3,819 | 2,167 | 1,336 | 674 |
| Income taxes - deferred | -786 | -1,775 | -1,083 | 0 | 0 |
| Accounts receivable | -34,595 | -178,480 | -84,557 | -7,437 | 104 |
| Accounts payable and accrued liabilities | -6,256 | 22,617 | 14,675 | 2,284 | 1,907 |
| Other Working Capital | 25,285 | -91,451 | -52,611 | -8,539 | 1,288 |
| Other Operating Activity | 45,615 | 171,588 | 79,778 | 7,948 | -651 |
| Operating Cash Flow | $233,179 | $140,628 | $6,372 | $-3,043 | $1,366 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -205,012 | -304,440 | -444 | -5,060 | -3,066 |
| PPE Investments | -11,479 | -35,122 | -11,328 | -1,207 | -796 |
| Purchase Of Investment | N/A | -3,971 | -3,971 | N/A | N/A |
| Sale Of Investment | N/A | 17,095 | 8,072 | N/A | N/A |
| Investing Cash Flow | $-216,491 | $-326,438 | $-7,671 | $-6,267 | $-3,862 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 29 | 15,019 | N/A | N/A | N/A |
| Common Stock Issued | 47,831 | 246,294 | 42,394 | -177 | -118 |
| Common Stock Repurchased | -513 | -62 | -46 | -46 | -46 |
| Financing Cash Flow | $47,347 | $261,251 | $42,348 | $-223 | $-164 |
| Exchange Rate Effect | N/A | 20 | 17 | -1 | -3 |
| Beginning Cash Position | 87,426 | 11,965 | 11,965 | 11,965 | 11,965 |
| End Cash Position | 151,461 | 87,426 | 53,031 | 2,431 | 9,302 |
| Net Cash Flow | $64,035 | $75,461 | $41,066 | $-9,534 | $-2,663 |
| Free Cash Flow | |||||
| Operating Cash Flow | 233,179 | 140,628 | 6,372 | -3,043 | 1,366 |
| Capital Expenditure | -11,492 | -35,130 | -11,336 | -1,207 | -796 |
| Free Cash Flow | 221,687 | 105,498 | -4,964 | -4,250 | 570 |